Brief: Si-Bone Announces FDA Clearance For Expanded Indication Of The Ifuse-Torq Implant System
13/06/2022 13:29
June 13 (Reuters) - SI-BONE Inc SIBN.O :
* SI-BONE, INC. ANNOUNCES FDA CLEARANCE FOR EXPANDED
INDICATION OF
THE IFUSE-TORQ® IMPLANT SYSTEM
Source text for Eikon: ID:nGNX676dX4
Further company coverage: SIBN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on SI-BONE
See all newsBrief: SI-BONE Enters Fourth Amendment To Lease On Sept 11, 2026 - SEC Filing
SI-BONE Inc reports results for the quarter ended June 30 - Earnings Summary
SI-BONE Q2 revenue beats estimates, raises 2026 revenue outlook
Brief: SI-BONE Q2 Revenue USD 56.01 Million Vs. IBES Estimate USD 55.3 Million
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis